199 related articles for article (PubMed ID: 22037655)
1. Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer.
Maurer J; Hipp M; Schäfer C; Kölbl O
Strahlenther Onkol; 2011 Nov; 187(11):744-9. PubMed ID: 22037655
[TBL] [Abstract][Full Text] [Related]
2. Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
Tribius S; Sommer J; Prosch C; Bajrovic A; Muenscher A; Blessmann M; Kruell A; Petersen C; Todorovic M; Tennstedt P
Strahlenther Onkol; 2013 Mar; 189(3):216-22. PubMed ID: 23354440
[TBL] [Abstract][Full Text] [Related]
3. Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles.
Deantonio L; Masini L; Brambilla M; Pia F; Krengli M
Strahlenther Onkol; 2013 Mar; 189(3):230-6. PubMed ID: 23319255
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
Lambrecht M; Nevens D; Nuyts S
Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
[TBL] [Abstract][Full Text] [Related]
5. Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma.
Mogadas S; Busch CJ; Pflug C; Hanken H; Krüll A; Petersen C; Tribius S
Strahlenther Onkol; 2020 Jun; 196(6):522-529. PubMed ID: 32006068
[TBL] [Abstract][Full Text] [Related]
6. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.
Hunter KU; Schipper M; Feng FY; Lyden T; Haxer M; Murdoch-Kinch CA; Cornwall B; Lee CS; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):935-40. PubMed ID: 23040224
[TBL] [Abstract][Full Text] [Related]
7. [Treatment related swallowing dysfunction and the potentialities of IMRT].
Dietzsch S; Melzer R; Boehm A; Wolf U; Kortmann R; Fuchs M
Laryngorhinootologie; 2011 Nov; 90(11):657-62. PubMed ID: 22083858
[TBL] [Abstract][Full Text] [Related]
8. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
9. Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment.
Carmignani I; Locatello LG; Desideri I; Bonomo P; Olmetto E; Livi L; Le Saec O; Coscarelli S; Mannelli G
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2159-2167. PubMed ID: 29978259
[TBL] [Abstract][Full Text] [Related]
10. Survivors' experiences of dysphagia-related services following head and neck cancer: implications for clinical practice.
Nund RL; Ward EC; Scarinci NA; Cartmill B; Kuipers P; Porceddu SV
Int J Lang Commun Disord; 2014; 49(3):354-63. PubMed ID: 24734913
[TBL] [Abstract][Full Text] [Related]
11. A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy : A systematic review by the Italian Head and Neck Radiotherapy Study Group.
Ursino S; D'Angelo E; Mazzola R; Merlotti A; Morganti R; Cristaudo A; Paiar F; Musio D; Alterio D; Bacigalupo A; Russi EG; Lohr F
Strahlenther Onkol; 2017 Nov; 193(11):877-889. PubMed ID: 28616822
[TBL] [Abstract][Full Text] [Related]
12. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic status and quality of life in patients with locally advanced head and neck cancer.
Tribius S; Meyer MS; Pflug C; Hanken H; Busch CJ; Krüll A; Petersen C; Bergelt C
Strahlenther Onkol; 2018 Aug; 194(8):737-749. PubMed ID: 29736758
[TBL] [Abstract][Full Text] [Related]
14. Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial.
Salas S; Baumstarck-Barrau K; Alfonsi M; Digue L; Bagarry D; Feham N; Bensadoun RJ; Pignon T; Loundon A; Deville JL; Zanaret M; Favre R; Duffaud F; Auquier P
Radiother Oncol; 2009 Dec; 93(3):503-9. PubMed ID: 19524315
[TBL] [Abstract][Full Text] [Related]
15. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer.
Langendijk JA; Doornaert P; Rietveld DH; Verdonck-de Leeuw IM; Leemans CR; Slotman BJ
Radiother Oncol; 2009 Feb; 90(2):189-95. PubMed ID: 19167120
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer.
Kraaijenga SA; Oskam IM; van der Molen L; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Oral Oncol; 2015 Aug; 51(8):787-94. PubMed ID: 26027851
[TBL] [Abstract][Full Text] [Related]
18. Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.
Buchapudi RR; Manickam R; M R AK; C R TP; Chandraraj V; Pyakuryal A; Narayanasamy G
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2463-2470. PubMed ID: 31450921
[TBL] [Abstract][Full Text] [Related]
19. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
[TBL] [Abstract][Full Text] [Related]
20. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
